GenSight Biologics S.A. (SIGHT.PA)

EUR 0.22

(-2.61%)

Operating Expenses Summary of GenSight Biologics S.A.

  • GenSight Biologics S.A.'s latest annual operating expenses in 2023 was 32.66 Million EUR , down -2.6% from previous year.
  • GenSight Biologics S.A.'s latest quarterly operating expenses in 2024 Q2 was 4.56 Million EUR , down 0.0% from previous quarter.
  • GenSight Biologics S.A. reported a annual operating expenses of 30.41 Million EUR in annual operating expenses 2022, down -8.93% from previous year.
  • GenSight Biologics S.A. reported a annual operating expenses of 33.4 Million EUR in annual operating expenses 2021, up 13.89% from previous year.
  • GenSight Biologics S.A. reported a quarterly operating expenses of 4.56 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • GenSight Biologics S.A. reported a quarterly operating expenses of 6.34 Million EUR for 2023 Q3, down -67.12% from previous quarter.

Annual Operating Expenses Chart of GenSight Biologics S.A. (2023 - 2013)

Created with Highcharts 11.1.0YearsOperating Expenses201320142015201620172018201920202021202220230 EUR10000000 EUR20000000 EUR30000000 EUR40000000 EUR

Historical Annual Operating Expenses of GenSight Biologics S.A. (2023 - 2013)

Year Operating Expenses Operating Expenses Growth
2023 32.66 Million EUR -2.6%
2022 30.41 Million EUR -8.93%
2021 33.4 Million EUR 13.89%
2020 29.32 Million EUR -5.39%
2019 30.99 Million EUR -6.19%
2018 33.04 Million EUR 37.75%
2017 23.98 Million EUR 8.95%
2016 22.01 Million EUR 61.18%
2015 13.66 Million EUR 102.59%
2014 6.74 Million EUR 137.57%
2013 2.83 Million EUR 0.0%

Peer Operating Expenses Comparison of GenSight Biologics S.A.

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -681.901%
ABIVAX Société Anonyme 127.37 Million EUR 74.359%
Adocia SA 15.62 Million EUR -108.971%
Aelis Farma SA 18.81 Million EUR -73.548%
Biophytis S.A. 14.33 Million EUR -127.866%
Advicenne S.A. 8.21 Million EUR -297.565%
genOway Société anonyme 16.73 Million EUR -95.122%
IntegraGen SA 5.35 Million EUR -510.181%
Medesis Pharma S.A. 1.56 Million EUR -1987.472%
Neovacs S.A. 10.34 Million EUR -215.752%
NFL Biosciences SA 4.37 Million EUR -646.625%
Plant Advanced Technologies SA 2.76 Million EUR -1081.258%
Quantum Genomics Société Anonyme 1.71 Million EUR -1801.086%
Sensorion SA 27.05 Million EUR -20.723%
Theranexus Société Anonyme 3 Million EUR -986.86%
TME Pharma N.V. 5.49 Million EUR -494.142%
Valbiotis SA 9.86 Million EUR -230.935%
TheraVet SA 1.64 Million EUR -1886.24%
Valerio Therapeutics Société anonyme 20.32 Million EUR -60.728%
DBV Technologies S.A. 89.4 Million EUR 63.47%
Genfit S.A. 54.8 Million EUR 40.406%
GeNeuro SA 14.35 Million EUR -127.48%
Innate Pharma S.A. 64.57 Million EUR 49.419%
Inventiva S.A. 120.18 Million EUR 72.825%
MaaT Pharma SA 21.59 Million EUR -51.218%
MedinCell S.A. 32.92 Million EUR 0.796%
Nanobiotix S.A. 58.92 Million EUR 44.575%
OSE Immunotherapeutics SA 23.58 Million EUR -38.454%
Poxel S.A. 28.76 Million EUR -13.541%
Transgene SA 31.23 Million EUR -4.576%
Valneva SE 134.92 Million EUR 75.794%